Outcome after portoenterostomy in biliary atresia: Pivotal role of degree of liver fibrosis and intensity of stellate cell activation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 1, 2006, Pages 93-99

  Shteyer, Eyal ^a   Ramm, Grant A ^b   Xu, Chunxia ^b   White, Frances V ^a   Shepherd, Ross W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Smooth muscle actin; Fibrogenesis; Hepatoportoenterostomy; Infant cholestasis; Outcomes

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIBIOTIC AGENT; ANTIFIBROTIC AGENT; BILIRUBIN;

ARTICLE; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DEATH; DISEASE SEVERITY; FEMALE; FIBROGENESIS; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFANT; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MORPHOMETRICS; PATHOLOGIST; PORTOENTEROSTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STELLATE CELL; SURVIVAL RATE; TREATMENT OUTCOME;

ACTINS; AGE FACTORS; BILIARY ATRESIA; BILIRUBIN; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MUSCLE, SMOOTH; PEROXIDASES; PORTOENTEROSTOMY, HEPATIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 30344462384     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189324.80323.a6     Document Type: Article

References (24)

1. Perlmutter DH, Shepherd RW. Extrahepatic biliary atresia: a disease or a phenotype? Hepatology 2002;35:1297-304.
2. Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 2003;37:4-21.
3. Kasai M, Watanabe I, Ohi R. Follow-up studies of long term survivors after hepatic portoenterostomy for "noncorrectible" biliary atresia. J Pediatr Surg 1975;10:173-82.
4. Nio M, Ohi R, Miyano T, Saeki M, Shiraki K, Tanaka K. Japanese Biliary Atresia Registry. Five- and 10-year survival rates after surgery for biliary atresia: a report from the Japanese Biliary Atresia Registry. J Pediatr Surg 2003;38:997-1000.
5. Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 1997;226:348-55.
6. Ryckman FC, Alonso MH, Balistreri WF. Biliary atresia: surgical management and treatment options as they relate to outcome. Liver Transpl Surg 1998;4(Suppl 1):S24-33.
7. Davenport M, Kerkar N, Mieli-Vergani G, Mowat AP, Howard ER. Biliary atresia: The King's College Hospital experience (1974-1995). J Pediatr Surg 1997;32:479-85.
8. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr 2003;144:123-5.
9. Zeitlin L, Resnick MB, Konikoff F, et al. Divergent patterns of extracellular matrix protein expression in neonatal versus adult liver fibrosis. Pediatr Pathol Mol Med 2003;22:349-62.
10. Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DH. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 1998;153:527-35.
11. Shivakumar P, Campbell KM, Sabla GE, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004;114:322-9.
12. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-35.
13. Huang CC, Chuang JH, Huang LL, et al. The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia. J Pathol 2004;202:172-9.
14. Ramm GA, Carr SC, Bridle KR, et al. Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver 2000;20:387-96.
15. 1 in cystic fibrosis liver disease. Am J Pathol 2002;160:1705-1710.
16. Ohi R, Shikes RH, Stellin GP, Lilly JR. In biliary atresia duct histology correlates with bile flow. J Pediatr Surg 1984;19:467-70.
17. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997;26:584-92.
18. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001;21:437-51.
19. Friedman SL. Liver fibrosis: from bench to bedside. J Hepatol 2003;38(Suppl 1):S38-53.
20. Bataller R, Brenner DA. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000;21:49-98.
21. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-74.
22. Chen L, Goryachev A, Sun J, et al. Altered expression of genes involved in hepatic morphogenesis and fibrogenesis are identified by cDNA microarray analysis in biliary atresia. Hepatology 2003;38:567-76.
23. Ramm GA, Hoskins AC, Greco SA, Pereira TN, Lewindon PJ. Signals for hepatic fibrogenesis in pediatric cholestatic liver disease: review and hypothesis. Comp Hepatol 2004;3(Suppl 1):1-5.
24. Hoofnagle JH. Biliary Atresia Research Consortium. Hepatology 2004;39:891.